Overtreatment of asymptomatic bacteriuria (ABU) is a quality, safety, and cost issue,
particularly as unnecessary antibiotics lead to emergence of resistant pathogens. The
investigators' proposal to bring clinical practice in line with published guidelines has
significant potential to reduce unnecessary antibiotic use for ABU in the VA healthcare
system, thus improving the quality and safety of veterans' healthcare. The investigators'
study will also provide important insights about how to implement and sustain evidence-based
clinical practice within VA hospitals.